Ozempic parent's stock having worst day since the 1980s

Dec 20, 2024  · The U.S.-listed shares of Novo Nordisk A.S. were plunging toward their worst day in decades on Friday after the results from a late-stage trial showed that the Danish …


Install CouponFollow Chrome Extension   CouponFollow Extension

20%
OFF

Novo Nordisk Shares Head For Worst Day Since The 1980s

3 weeks from now

Shares of Ozempic-maker Novo Nordisk were down more than 20% in recent trade as the Danish drugmaker headed for its worst day since the 1980s. The stock took a hit after a late-stage trial …

marketwatch.com

18%
OFF

Novo Nordisk Heads For Worst Day In 22 Years As New Obesity …

3 weeks from now

Dec 20, 2024  · Novo Nordisk shares plunged 18% Friday afternoon and were headed for their worst intraday drop since April 2002. However, retail investors have seemingly brushed off the …

stocktwits.com

27%
OFF

Novo Nordisk Shares Plummet After Weight-loss Drug’s …

3 weeks from now

Dec 20, 2024  · Novo’s shares fell as much as 27% after the results were announced, hitting their lowest since August 2023 in one of the biggest one-day wipeouts on record for a European …

nypost.com

15%
OFF

Novo Nordisk Faces 20-Year Worst Stock Drop: Bear Market Price …

3 weeks from now

Dec 20, 2024  · Novo Nordisk shares fell over 15% as obesity drug results missed targets, fueling a deeper bear market trend. ... Friday’s decline in Novo Nordisk shares marked the worst one …

moneymorning.com

20%
OFF

Novo Nordisk Shares Plunge On The Back Of Disappointing

3 weeks from now

Dec 23, 2024  · Novo Nordisk shares have plunged 20% amid the disappointing trial result of its latest weight-loss drug CagriSema. The fall wiped out €90bn in market valuation on Friday.

euronews.com

20%
OFF

Novo Nordisk Shares Plunge 20% After Disappointing Trial Results; …

3 weeks from now

Dec 20, 2024  · Shares of Novo Nordisk plummeted roughly 20% on Friday. The fall comes after the Danish pharmaceutical giant reported results in a late-stage trial for its experimental …

nbcchicago.com

32%
OFF

Why Novo Nordisk Stock Was Up On A Down Day For The Market

3 weeks from now

Dec 20, 2023  · One was Denmark-based pharmaceutical sector star Novo Nordisk (NVO-0.32%), which ended the day more than 1% higher. A positive story in a major newspaper about the …

fool.com

€90
OFF

Novo Nordisk Shares Tumble As Data On Weight-loss Drug Trial …

3 weeks from now

Dec 20, 2024  · Novo Nordisk’s shares fell sharply on Friday as disappointing results from tests of its latest obesity drug wiped about €90bn off the valuation of Europe’s largest company by …

ft.com

27%
OFF

Novo Nordisk’s 27% Drop On Friday Was A Market Overreaction

3 weeks from now

N ovo Nordisk’s shares recovered some ground ... Ozempic parent’s stock having worst day since the 1980s as new weight-loss drug disappoints. In a worst-case scenario, Novo Nordisk is still ...

msn.com

20%
OFF

Novo Nordisk Stock Crashes More Than 20% After Disappointing …

3 weeks from now

Novo Nordisk stock fell sharply after the Ozempic maker’s experimental obesity drug CagriSema disappointed investors. Eli Lilly Shares Soar.

barrons.com

7%
OFF

Novo Nordisk Shares Plunge After CagriSema Obesity Drug Trial ...

3 weeks from now

Dec 20, 2024  · The CagriSema trial showed the drug helped patients cut their weight by 22.7%, below the 25% Novo Nordisk had expected. Novo’s shares fell as much as 27% after the …

financialnewsletter.com

20%
OFF

Novo Nordisk Stock Eyes Worst Day, Week On Record

3 weeks from now

Dec 20, 2024  · Novo Nordisk (NVO) stock is gapping lower today, after the company's disappointing weight loss drug results ... Shares now carry a 20% deficit for 2024, and earlier …

schaeffersresearch.com

88%
OFF

Why Novo Nordisk (NVO) Dipped More Than Broader Market Today

3 weeks from now

4 days ago  · Novo Nordisk (NVO) closed at $85.73 in the latest trading session, marking a -1.88% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 1.07% …

nasdaq.com

20%
OFF

Novo Nordisk Stocks Plummet Over 20% On Disappointing Weight …

3 weeks from now

Dec 21, 2024  · TMTPOST -- Novo Nordisk A/S shares plummeted as much as 27%, wiping up to $125 billion off in the market value, and settled 20.8% lower on Friday. Shares registered their …

sohu.com

5%
OFF

Novo Nordisk Shares Drop Nearly 5% On Disappointing Obesity Pill …

3 weeks from now

Sep 20, 2024  · LONDON/COPENHAGEN (Reuters) -Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental obesity pill …

yahoo.com

5%
OFF

Novo Nordisk Shares Drop Nearly 5% On Disappointing Obesity …

3 weeks from now

Sep 20, 2024  · Novo Nordisk shares were down 4.8% at 1407 GMT, at their lowest level in more than five weeks. That weight loss is "not what optimists are looking for", Nordnet analysts said. …

usnews.com

FAQs about Ozempic parent's stock having worst day since the 1980s Coupon?

Why did Novo Nordisk stock go down 20%?

Shares of Ozempic-maker Novo Nordisk were down more than 20% in recent trade as the Danish drugmaker headed for its worst day since the 1980s. The stock took a hit after a late-stage trial showed that the company’s new weight-loss drug works better than current GLP-1 drugs — but not as well as expected. ...

Why did Novo Nordisk stock dive?

Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares. Shares of Ozempic-maker Novo Nordisk were down more than 20% in recent trade as the Danish drugmaker headed for its worst day since the 1980s. ...

Why did Novo Nordisk's shares fall 5% on Friday?

LONDON/COPENHAGEN (Reuters) -Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental obesity pill monlunabant came in below market expectations. ...

What if Novo Nordisk's losses hold?

If its current losses hold, the stock would tally its worst showing since Oct. 19, 1987 -- a day known on Wall Street as "Black Monday." Novo Nordisk’s stock dives as new weight loss drug disappoints in a late-stage trial, which gave a boost to Eli Lilly shares. ...

Why did Novo Nordisk stock tank?

Novo Nordisk's stock tanked after a highly anticipated drug trial disappointed. The study showed its new obesity drug helped people lose less weight than expected. Eli Lilly, a competitor in the market for GLP-1 weight loss drugs, was up about 5%. ...

What happened to Novo Nordisk?

The drugmaker’s shares were down as much as 27 per cent in mid-morning trading in Denmark before mounting a partial recovery to close 21 per cent lower. Barclays analyst Emily Field said the market was having an “emotional reaction” to Novo Nordisk not hitting the 25 per cent weight loss bar it had set. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension